BioNTech SE (VIE:BNTX)
86.75
-0.20 (-0.23%)
Last updated: Apr 29, 2026, 11:00 AM CET
BioNTech SE Employees
BioNTech SE had 7,807 employees as of December 31, 2025. The number of employees increased by 1,035 or 15.28% compared to the previous year.
Employees
7,807
Change (1Y)
1,035
Growth (1Y)
15.28%
Revenue / Employee
€367,606
Profits / Employee
€145,523
Market Cap
22.00B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| VERBUND AG | 4,689 |
| OMV Aktiengesellschaft | 22,315 |
| Raiffeisen Bank International AG | 42,927 |
| Erste Group Bank AG | 49,024 |
| BAWAG Group AG | 4,042 |
| Strabag SE | 79,159 |
| Vienna Insurance Group AG | 30,000 |
| Voestalpine AG | 48,744 |
BioNTech SE News
- 7 days ago - Two experimental drugs showed striking early results against pancreatic cancer - WSJ
- 7 days ago - BioNTech to Report First Quarter 2026 Financial Results and Corporate Update on May 5, 2026 - GlobeNewsWire
- 17 days ago - BioNTech and DualityBio's Antibody-Drug Conjugate Trastuzumab Pamirtecan Demonstrated Clinically Meaningful Efficacy in Patients with HER2-Expressing, Recurrent Endometrial Cancer - GlobeNewsWire
- 27 days ago - Exclusive: Pfizer, BioNTech halt US COVID vaccine study after recruitment struggles - Reuters
- 5 weeks ago - BioNTech Clinical Data at ELCC 2026 Highlight Potential of Differentiated Late-Stage Portfolio in Lung Cancer - GlobeNewsWire
- 7 weeks ago - BioNTech Stock Tanks As Outlook, Founder Exit Rattle Bulls - Benzinga
- 7 weeks ago - BioNTech SE Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses - GlobeNewsWire
- 7 weeks ago - One simple reason why BioNTech stock is a raging buy on today's crash - Invezz